Dynasty Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
7,916
+2,428
+44% +$320K 0.01% 190
2026
Q1
$765K Buy
5,488
+1,208
+28% +$169K 0.01% 199
2025
Q4
$525K Buy
+4,280
New +$520K 0.01% 238

Other funds holding GILD

Dynasty Wealth Management's GILD Position: Q2 2026 in Review

Dynasty Wealth Management increased its Gilead Sciences (GILD) stake by 44% in Q2 2026, buying an estimated $320K and bringing the position to 7,916 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #190.

Dynasty Wealth Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Dynasty Wealth Management held 7,916 shares of Gilead Sciences worth $1M as of Q2 2026.
  • Dynasty Wealth Management bought 2,428 Gilead Sciences shares in Q2 2026, an estimated $320K.
  • Gilead Sciences made up 0.01% of Dynasty Wealth Management's portfolio in Q2 2026, its #190 holding.
  • Dynasty Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Dynasty Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.